Edgewise Therapeutics Inc
Ownership
Ownership Structure
Who owns Edgewise Therapeutics Inc (EWTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.4% of the shares are freely tradable; institutional investors hold 113.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Orbimed Advisors LLC | 14.29 | 15,518,492 | +0.0 | 03/31/2026 |
| RA Capital Management, LLC | 9.60 | 10,428,437 | +0.0 | 03/31/2026 |
| Paradigm Biocapital Advisors LP | 9.41 | 10,215,455 | +38.7 | 06/30/2026 |
| Baker Bros Advisors LP | 6.06 | 6,575,940 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.96 | 6,472,991 | -2.4 | 03/31/2026 |
| HHG PLC | 5.45 | 5,915,556 | +29.5 | 03/31/2026 |
| Novo A/S | 4.93 | 5,350,000 | +0.0 | 03/31/2026 |
| Driehaus Capital Management LLC | 4.12 | 4,477,942 | +6.8 | 03/31/2026 |
| Siren, L.L.C. | 4.08 | 4,430,263 | -2.2 | 03/31/2026 |
| Perceptive Advisors LLC | 4.03 | 4,373,974 | -1.1 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Koch Kevin | President and CEO | 52,488 | 2,461,687 $ | Aug 12, 2026 | direct |
| Derakhshan Behrad | Chief Business Officer | 31,826 | 1,492,639 $ | Aug 12, 2026 | direct |
| Russell Alan J | Chief Scientific Officer | 31,466 | 1,475,755 $ | Aug 12, 2026 | direct |
| Moore John R | General Counsel | 17,697 | 829,989 $ | Aug 12, 2026 | direct |
| Donovan Joanne M. | CMO | 8,625 | 404,513 $ | Aug 13, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Donovan Joanne M. | CMO | Sell | 2,919 | 43.41 | 126,704 |
| Aug 12, 2026 | Russell Alan J | Chief Scientific Officer | Sell | 390 | 44.46 | 17,339 |
| Aug 12, 2026 | Russell Alan J | Chief Scientific Officer | Sell | 2,273 | 43.68 | 99,275 |
| Aug 12, 2026 | Russell Alan J | Chief Scientific Officer | Sell | 3,238 | 43.68 | 141,428 |
| Aug 12, 2026 | Russell Alan J | Chief Scientific Officer | Other | 7,031 | 0.00 | – |
| Aug 12, 2026 | Russell Alan J | Chief Scientific Officer | Other | 5,781 | 0.00 | – |
| Aug 12, 2026 | Derakhshan Behrad | Chief Business Officer | Sell | 2,475 | 43.70 | 108,154 |
| Aug 12, 2026 | Derakhshan Behrad | Chief Business Officer | Sell | 150 | 44.44 | 6,667 |
| Aug 12, 2026 | Derakhshan Behrad | Chief Business Officer | Sell | 304 | 44.50 | 13,529 |
| Aug 12, 2026 | Derakhshan Behrad | Chief Business Officer | Sell | 2,171 | 43.79 | 95,075 |
| Aug 12, 2026 | Derakhshan Behrad | Chief Business Officer | Other | 7,500 | 0.00 | – |
| Aug 12, 2026 | Derakhshan Behrad | Chief Business Officer | Other | 5,781 | 0.00 | – |
| Aug 12, 2026 | Donovan Joanne M. | CMO | Sell | 800 | 44.52 | 35,614 |
| Aug 12, 2026 | Donovan Joanne M. | CMO | Sell | 104 | 44.43 | 4,620 |
| Aug 12, 2026 | Donovan Joanne M. | CMO | Sell | 2,779 | 43.71 | 121,463 |
| Aug 12, 2026 | Donovan Joanne M. | CMO | Sell | 2,839 | 43.78 | 124,303 |
| Aug 12, 2026 | Donovan Joanne M. | CMO | Other | 7,031 | 0.00 | – |
| Aug 12, 2026 | Donovan Joanne M. | CMO | Other | 5,781 | 0.00 | – |
| Aug 12, 2026 | Moore John R | General Counsel | Sell | 2,419 | 43.80 | 105,949 |
| Aug 12, 2026 | Moore John R | General Counsel | Sell | 99 | 44.50 | 4,406 |
| Aug 12, 2026 | Moore John R | General Counsel | Sell | 59 | 44.41 | 2,620 |
| Aug 12, 2026 | Moore John R | General Counsel | Sell | 2,439 | 43.81 | 106,848 |
| Aug 12, 2026 | Moore John R | General Counsel | Other | 6,718 | 0.00 | – |
| Aug 12, 2026 | Moore John R | General Counsel | Other | 5,781 | 0.00 | – |
| Aug 12, 2026 | Koch Kevin | President and CEO | Sell | 913 | 44.33 | 40,473 |
| Aug 12, 2026 | Koch Kevin | President and CEO | Sell | 8,276 | 43.66 | 361,315 |
| Aug 12, 2026 | Koch Kevin | President and CEO | Sell | 8,782 | 43.64 | 383,254 |
| Aug 12, 2026 | Koch Kevin | President and CEO | Other | 21,875 | 0.00 | – |
| Aug 12, 2026 | Koch Kevin | President and CEO | Other | 17,969 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.